Armata PharmaceuticalsARMP
13F holders, Q3 2025 (September 30)28holders −1
2new positions
3sold out
1famous investor
$2.99avg. 13F price*
At the end of Q3 2025, 28 institutions reported holding Armata Pharmaceuticals Inc. (ARMP) in their 13F filings, down 1 from Q2 2025. 2 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($885K), Geode Capital Management, LLC ($312K) and Edgewood Management LLC ($298K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Armata Pharmaceuticals Inc.
- CUSIP
- 04216R102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3K |
| Exits | 3 | $29K |
All 13F filers, Q2 2025 → Q3 2025: 41,162 shares bought and 16,657 shares sold, net +24,505 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Vanguard Group Inc. | 0.00% | Add +14.2% | 297,038 | $885K |
| Geode Capital Management, LLC | 0.00% | No change | 104,546 | $312K |
| Edgewood Management LLC | 0.00% | No change | 100,000 | $298K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 44,682 | $133K |
| Renaissance Technologies | 0.00% | Add +6.2% | 41,296 | $123K |
| State Street Corp. | 0.00% | No change | 40,300 | $120K |
| SeaCrest Wealth Management, LLC | 0.01% | No change | 34,954 | $113K |
| Grey Ledge Advisors, LLC | 0.02% | No change | 30,000 | $89K |
| BlackRock, Inc. | 0.00% | Add +2.9% | 26,666 | $79K |
| Northern Trust Corp. | 0.00% | No change | 19,273 | $57K |
| Captrust Financial Advisors | 0.00% | No change | 13,140 | $39K |
| Group One Trading LLC | 0.00% | No change | 3,000 | $9K |
| Cornerstone National Bank & Trust Co | 0.00% | No change | 1,428 | $4K |
| Measured Wealth Private Client Group, LLC | 0.00% | New | 1,000 | $3K |
| Trifecta Capital Advisors, LLC | 0.00% | No change | 714 | $2K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 571 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 457 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -79.2% | 355 | $1K |
| Salem Investment Counselors Inc. | 0.00% | No change | 100 | $298 |
| Team Financial Group, LLC | 0.00% | No change | 71 | $212 |
| MAI Capital Management | 0.00% | No change | 71 | $212 |
| UBS Group AG | 0.00% | Add +4300.0% | 44 | $131 |
| JPMorgan Chase & Co. | 0.00% | No change | 24 | $72 |
| Bank of America Corp. | 0.00% | Reduce -93.2% | 7 | $21 |
| Barclays PLC | 0.00% | New | 6 | $18 |
| SBI Securities Co., Ltd. | 0.00% | No change | 3 | $9 |
| Morgan Stanley | 0.00% | Reduce -98.2% | 2 | $6 |
| Wells Fargo & Company | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is ARMP's weight in each manager's 13F, not the share of Armata Pharmaceuticals Inc. the manager owns.